Back to Search Start Over

Arid5a: A missing link between EMT and tumoral immune resistance

Authors :
Benoît Van den Eynde
UCL - SSS/DDUV/GECE - Génétique cellulaire
Source :
Cancer immunology research, Vol. 9, no.8, p. 854 (2021)
Publication Year :
2023
Publisher :
American Association for Cancer Research, 2023.

Abstract

Epithelial-to-mesenchymal transition (EMT) endows tumor cells with the ability to invade and migrate, and to suppress antitumor immunity. In this issue, Parajuli and colleagues report that EMT tumors often express the RNA-binding protein AT-rich interactive domain 5a (Arid5a), which they find stabilizes the mRNAs encoding indoleamine 2,3 dioxygenase (IDO1) and CCL2. As a new link between EMT and tumoral immune resistance, Arid5a represents a therapeutic target of interest. See related article by Parajuli et al., p. 862 (4).

Details

Language :
English
Database :
OpenAIRE
Journal :
Cancer immunology research, Vol. 9, no.8, p. 854 (2021)
Accession number :
edsair.doi.dedup.....14f135711e8cd6cd825a3ce13cf9c2ec